[Preventive relapse treatment for tobacco cessation - is it worthwhile?]

Area of Science:

• Addiction Medicine
• Behavioral Psychology
• Pharmacology

Background:

• Despite existing tobacco cessation treatments, relapse remains a significant challenge for many smokers.
• Existing research often suffers from inadequate study design and insufficient participant numbers, limiting reliable conclusions.

Purpose of the Study:

• To provide an overview of tobacco relapse prevention strategies.
• To evaluate the efficacy of psychological and pharmacological interventions in preventing relapse after smoking cessation.

Main Methods:

• Review of selected trials and a recent meta-analysis on tobacco relapse prevention.
• Analysis of randomized controlled trials involving both selected and unselected smoker groups.
• Evaluation of pharmacological interventions, including nicotine replacement therapy, Bupropion, and Varenicline.

Main Results:

• Psychological interventions, primarily behavioral skills-based approaches, showed no significant advantage in preventing relapse.
• Nicotine replacement therapy and Bupropion did not demonstrate benefits in relapse prevention.
• One study indicated that prolonged Varenicline treatment significantly reduced relapse rates.

Conclusions:

• Currently, there is insufficient evidence to recommend systematic psychological or pharmacological relapse prevention treatments for tobacco addiction.
• Extended Varenicline treatment shows potential for reducing relapse rates post-cessation.
• Further high-quality, well-powered trials are needed to establish effective relapse prevention strategies.